 Analysts expect that Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA will announce 0.62 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Kiniksa Pharmaceuticals earnings, with the highest EPS estimate coming in at 0.60 and the lowest estimate coming in at 0.63. Kiniksa Pharmaceuticals reported earnings of 1.27 per ... 